How much funding has PlasmaCure raised?

PlasmaCure has raised $8.2M in total funding, most recently a Series A round.

When was PlasmaCure founded?

PlasmaCure was founded in 2014.

Where is PlasmaCure headquartered?

PlasmaCure is headquartered in Nijmegen, Netherlands.

What industry is PlasmaCure in?

PlasmaCure operates in Biotech, Healthcare.

How many employees does PlasmaCure have?

PlasmaCure has 11-50 employees.

PlasmaCure

Q: Who are PlasmaCure's investors?

PlasmaCure's investors include European Innovation Council Fund, Noaber.

Nijmegen, Netherlands · Founded 2014 · $8.2M raised

Biotech

Healthcare

Headquarters: Nijmegen
Employees: 11–50
Founded: 2014
Business Model: B2B

Website: plasoma.com
Total Funding: $8.2M
Last Round: $6.5M Series AJul 2025
Rounds: 3

About

Plasmacure is a Nijmegen-based MedTech scale-up developing the PLASOMA cold-plasma system for treating chronic, complex wounds that fail to heal with conventional care. The device applies cold atmospheric plasma directly to wound sites to help kill bacteria and stimulate tissue repair. In 2026 the company raised a €6 million Series A round to expand its cold-plasma wound-care platform across Europe.

Summary

PlasmaCure is a Biotech company based in Nijmegen, Netherlands, founded in 2014. It has raised $8.2M in total across 3 rounds, most recently a $6.5M Series A round in Jul 2025. Investors include European Innovation Council Fund and Noaber.